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ROLE OF FASTING IN CALORIC RESTRICTION IMPROVED GLUCOSE
TOLERANCE

MAKAYLA DILLON
ABSTRACT

The Caloric Restriction (CR) diet in mammals has been shown to increase longevity
and prevent metabolic disorders. Some of the benefits of CR include improved glucose

homeostasis, namely improvements in glucose tolerance. Mice on the CR diet have a 30%
reduction in food provided, as well as a fasting period between meals as they are only fed

once a day. Hence the benefits of CR stem from both fasting and reduced calorie intake. In
this study, we investigated if the fasting component of CR is responsible for the benefits
of this diet in improving glucose homeostasis. In particular, we used glucose tolerance tests
to show that varying durations of fasting affect the glucose tolerance of fasted mice

differently. Shorter fasts improved glucose tolerance, while longer fasts showed similar or
reduced tolerance compared to non-fasted mice. Ultimately, we observed that fasting may

be responsible for a part of the benefits of CR, but it is not the only contributor to the
advanced glucose tolerance and homeostasis of mice on CR.
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CHAPTER I
INTRODUCTION

The prevalence of negative diseases attributed to metabolic imbalance, namely

disruption in glucose homeostasis, in the United States is staggering and rapidly increasing.

Metabolic imbalance encompasses a plethora of various health conditions that often
accumulate, leading to the development and progression of potentially life threatening
pathologies. The most alarming of pathologies being that cardiovascular disease (CVD) is

the leading cause of death in the United States, one person dying every 36 seconds from
the disease (CDC, 2022). These health conditions have a broad, and overall detrimental

impact to the body, diversely targeting a range of the human body systems. Common

health conditions which are closely tied to metabolic imbalance include, non-alcoholic
fatty liver disease, high blood pressure, low HDL cholesterol, high triglyceride levels, high
fasting glucose levels, low fasting insulin levels, central obesity, polycystic ovarian

syndrome, erectile dysfunction, glucose intolerance and mental fatigue (NIH, 2020). If an

individual is concurrently suffering from a minimum of three or more of these health
conditions, they are formally diagnosed with a pathology termed ‘Metabolic Syndrome’.

Metabolic Syndrome can increase the risk of a variety of secondary diseases, such as
cardiovascular disease, stroke, and type 2 diabetes. Similar to the signs of metabolic
1

imbalance, the prevalence of Metabolic Syndrome is shockingly high. Across the United
States, Metabolic Syndrome affects one out of every three people (CDC, 2020).
Furthermore, as individuals age, the risk of Metabolic Syndrome dramatically increases,
affecting nearly half of American adults over the age of 60 (CDC, 2020). Metabolic
Syndrome is closely linked with other metabolic diseases such as obesity and diabetes.

This is reinforced by the statistic that 85% of those suffering from Metabolic Syndrome
are also diagnosed with a form of diabetes (CDC, 2020).

1.1 Influential Determinants of Metabolic Health
The causes of the previously mentioned ailments are complex and include a

complicated network of frequently overlooked factors, such as genetic predisposition,
socioeconomic status, and environmental influences. Though the influence of these factors

on metabolic diseases remains unclear, research has found trends in genetic
predispositions, socioeconomic status, and environmental influences that correlate with
certain diseases. An influence on metabolism-related conditions that can, at times, be
predictable is genetic predisposition, or heritability. Abdominal fat is one of the important
risk factors that, when combined with others, result in Metabolic Syndrome. Heritability
estimates for waist circumference range from 39-76% (Elder, 2009). Heritability estimates

8-51% for fasting insulin, 7-77% for fasting glucose, and 8-59% for insulin resistance

assessed by the homeostatic model assessment of insulin resistance (HOMA-IR) - all
measures are telling quantifications of metabolic health (Elder, 2009). For fasting HDL
cholesterol, heritability estimates for 21-79% and 19-72% for fasting triglycerides, both

risk factors for Metabolic Syndrome (Elder, 2009). These percentage estimates of
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heritability mean that some individuals can only control for a small portion of their

disposition to metabolic disease.

In addition to genetic predisposition, socioeconomic status has been shown to
greatly impact metabolic health, more specifically CVDs (Schultz, 2018). Income level has

been regularly associated with metabolic disease, this may be due to low-income patients
experiencing disparities in standards of care because they lack the access to higher quality

care (Schultz, 2018). Often linked with income level, education has been shown to
inversely impact risk factors for CVD (Kucharska-Newton, 2011). Those with less

education experience more metabolic risk factors, possibly attributed to the well-studied
relationship between education and health literacy (Winkleby, 1992). Individuals with less

education are often poorer in health literacy, these individuals tend to be less compliant
with medication protocols, medical advice, and prevention strategies- these all

contributing to all cause mortality (Bostock, 2012). Commonly used as a determinant of
socioeconomic status, employment status has been shown to affect risk of metabolic

diseases (Meneton, 2015). This may be due to increased levels of stress because of the
potential job loss that led to the unemployment, the stress of being unemployed itself, or
simply that individuals in poorer health are more likely to be unemployed than those with

good health (Schultz, 2018).

We have seen that genetic predisposition and socioeconomic status influence health

outcomes in very measurable ways. On top of these two influences, the environment in

which an individual exists plays a prominent role in nearly every aspect of their health,
especially in association to metabolic diseases. Environmental influences can encompass
several elements, such as substance use, pollutants, residence location, safety, community
3

socialization, and many more. In a study done in young and healthy smokers versus non
smoking individuals, researchers saw that the risk of hypertriglyceridemia and low HDL

levels were higher in smokers (Woo Kim, 2021). This same study determined that smokers
had a 2.4-fold greater risk of developing Metabolic Syndrome than non-smokers (Woo

Kim, 2021). Alcohol is another common substance that is well known to negatively impact

health, excessive consumption has been linked to various components of Metabolic
Syndrome, such as hypertension and obesity (Hernandez-Rubio, 2022). In a study
comparing non-drinkers, light drinkers (mean: 5.1drinks/week), and heavy drinkers (mean:

30.7 drinks/week), heavy drinkers had the highest body mass index (BMI), waist

circumference, obesity prevalence, hypertension, and hyperglycemia (Jung Choi, 2016). It

was determined that heavy drinkers had a 1.71 times larger risk of developing Metabolic
Syndrome than non-drinkers (Jung Choi, 2016). Substance use, such as smoking or

drinking are usually voluntary behaviors and can be controlled for.

Harder to control for are environmental influences that individuals are typically bom
into with no choice: pollutants, neighborhood location and condition, and safety.

Differences in neighborhood conditions impact the availability of resources, such as access
to and promotion of healthy food, or an area conducive to physical activity. Overlooked

features such as lowering the cost of healthy food or making exercise more accessible with

easy walking paths, pleasant views, and access to resources via walking may affect
metabolic health more than an educational campaign (Roux, 2003). A study done
evaluating

biological

risk

via

cardiovascular,

inflammatory,

metabolic,

and

neuroendocrine health reported a relationship between poor health and neighborhood

disadvantage (Barber, 2015). Evaluating BMI with neighborhood crime and safety in 673
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adults in Chicago, Illinois, researchers found that over time, increasing individual- and
neighborhood-level safety were linked with reduced BMI and subsequent decreased risk

of cardiovascular health (Powell-Wiley, 2017). Environmental influences that, at times,
cannot be controlled, similar to genetic predisposition and socioeconomic status, have

tangible influence on metabolic health.

1.2 Glucose Homeostasis
Glucose homeostasis is an essential part of maintaining metabolic balance, as its

disruption is implicated in several life-threatening pathologies, including Metabolic
Syndrome. Glucose homeostasis is governed by two crucial peptide signals: insulin and

glucagon. Insulin is synthesized and stored in the pancreas where it is released from

pancreatic beta cells in response to a rise in blood glucose. A practical example of this
occurs after eating a large meal. Insulin acts as a signal to stimulate the uptake of glucose
by the cells as a response to high glucose levels in the blood. As a result, blood glucose

levels return back down to a homeostatic range. Additionally, glucose uptake stimulated
by insulin release enables the liver to create glycogen stores from glucose as a reserve in
the case of an energy shortage.

The counterpart of glucose homeostasis via insulin involves another peptide known

as Glucagon. Glucagon is stored and released from pancreatic alpha cells as the body senses
a drop in blood glucose levels during a fasted or starved state. Glucagon acts as a signal to

the liver and muscle cells, traveling through the bloodstream and binding to its G-protein-

coupled-receptor (GPCR) known as the glucagon receptor. Once bound, Glucagon acts to

break down glycogen stores into smaller glucose molecules, prompting its release into the
blood. As a result, blood glucose levels rise and can return back to homeostatic levels.
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Disruption of glucose homeostasis is linked to aging, a variable that makes nearly all

metabolic conditions considerably worse (Spinelli, 2020). The risk factors produced by
metabolic imbalance can be prevented or reduced with an improvement in metabolic
balance. This improvement can be achieved through changes in diet and exercise.

1.3 Caloric Restriction and Glucose Homeostasis
One of the hallmark symptoms implicated in Metabolic Syndrome is an overall
increase in blood glucose as a result of an impaired glucose tolerance and reduced insulin
sensitivity (Mezhnina, 2020). In our lab, we study a diet that aims to address metabolic

disorder, known as Caloric Restriction (CR). CR is a dietary paradigm in which the daily

intake of food is reduced while avoiding malnutrition. CR is recognized for its benefits
to health which drive the extension of lifespan in several mammals (Froy & Miskin,

2010; Mitchell et al., 2016). Mice placed on a long term CR diet have overall improved
glucose homeostasis, meaning they have an improved ability to regulate their blood
glucose levels. CR has been shown to positively impact metabolism through reduced

blood glucose, improved glucose tolerance, and increased insulin sensitivity in CR
mammals for over a hundred years (Mezhnina, 2020).

On a molecular level, CR affects several signaling pathways known to be
associated with aging, cellular growth, and cellular metabolism such as the IGF, mTOR,

AMPK, and sirtuin signaling pathways. (Balasubramanian, Howell, & Anderson, 2017).
In the IGF-1 receptor pathway, a CR based eating regimen has been shown to reduce

serum IGF-1 levels by up to 40%, potentially decreasing the risk of cancer and diabetes
associated with the upregulation of IGF-1 and its action (Fontana et al., 2008)(Blackburn,

2017). CR diet has additionally been shown to downregulate the mTOR pathway through
6

decreased PI3K activation and increased AMPK phosphorylation (Arbor, 2018). These
molecular changes ultimately act to reduce the rate of cell growth and metabolism, that of

which is broadly implicated in the acceleration of cancer, diabetes, and aging. Thus, the
controlled regulation of cell growth and metabolism through CR may be a beneficial

method to combat these ailments. A known factor that plays a role in regulating these
major metabolic and growth pathways is the circadian clock. The circadian clock

generates 24-hour rhythms in physiology and metabolism in a diverse amount of
organisms across taxa, working in most tissues and organs (Green et al., 2008) (Lowrey

& Takahashi, 2004). For example, previous studies in our lab have shown the undisrupted

circadian clock is necessary for a homeostatic modulation of mTOR signaling (Apelo,
2016). However, it has been shown that pharmacological inhibition of mTOR activity
improves lifespan in both wild type mice and mice with a disrupted clock (Apelo, 2016).

Notably, CR reduces mTOR signaling in wildtype mice, which is agreed upon to be one

of the mechanisms by which CR extends lifespan. Interestingly, fluctuations in
accessibility to food is a defining characteristic that contributes to physiological circadian
rhythm, indicating an interaction between the circadian clock and eating patterns such as

CR.

Mice represent the most commonly used mammalian model for research protocols

due to their physiological, anatomical, and genetic resemblance to humans. For these
similarities, the mouse is our model animal of choice. As a way to study and control for

the contribution of circadian rhythm during a CR diet, mice used in our experiments are
subjected to a 12 hour light-dark cycle (LD). The lights are on for 12 hours, then off for

the next 12 hours. Mice are nocturnal animals, and they are at their most active during the
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12 hour dark phase. Mice on the CR diet are given a 30% reduction in food and only fed

once daily, two hours after the lights are turned off, as this makes physiological sense
due to their nocturnality.

1.4 CR as a Periodic Fast
In addition to mice on the CR diet, there are mice on an Ad libitum (AL) diet. The

mice on the AL diet have accessibility to food at all times during the LD. A food intake
study previously done measuring food intake around the clock for both CR and AL diets
shows that AL mice consume food at all times during the LD, but mainly consume the

food during the dark phase (Velingkaar, 2020). The same food intake study revealed that
CR mice eat their reduced food within two hours, leaving them in a state of fasting until

they are fed again 22 hours later (Velingkaar, 2020). CR contains two components that
are hypothesized to be beneficial: calorie restriction and fasting. Many have speculated

that the benefits of CR are contributed to the fasting aspect of the diet. Because of this,
diets that only implement the fasting aspect of CR without the calorie reduction have

been studied.

One of the alternatives to CR that isolates the fasting variable is Time Restricted

Feeding (TRF). TRF allows the subjects to feed freely, but only for a certain period of
time. This introduces the aspect of periodic fasting which is similar to that of CR. TRF is

also similar to intermittent fasting due to including an overall longer window of fasting
(Jamshed, 2019). A pre-clinical trial study implementing TRF in humans placed one

group on a 4 hour TRF, another on a 6 hour TRF, and the third group was without any
food restriction (Cienfuegos, 2020). Both TRF groups demonstrated weight loss along
with other mild benefits, but there is no definitive way to attribute these benefits to
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fasting alone, as TRF does ultimately reduce total caloric intake in addition to the fast

(Cienfuegos, 2020). A separate study examining TRF showed no benefits relevant to
glucose metabolism after introducing humans to a time restriction of 8 hours to feed,

without reducing calories (Lowe, 2020). Studies examining TRF have results

inconsistent with one another, and this is possibly due to several variables at play, such as
the time of TRF, the amount of time TRF is implemented, the caloric intake during these

studies, or comorbidities in subjects (Lowe, 2020). Currently, the accumulated evidence
does not suggest TRF to be an equal alternative both in efficacy and benefit to CR, but it

is deemed as slightly more convenient in the context of practicality. Controlling a
window of time in which a person eats is less complicated and more convenient than

reducing caloric intake as a whole.

There is much to be investigated surrounding the mechanism of CR and whether
fasting is the main contributor to these benefits. A study aimed to address the role of
fasting in CR found that improvements in glucose homeostasis occur only in diets that
incorporate fasting in tandem with reduced caloric intake (Velingkaar, 2020). In that

study, 12 hour TRF with no caloric reduction was compared to AL and CR. An increase
in insulin sensitivity and reduction in blood insulin was observed in both the TRF and CR
diets compared to AL, but only CR had improvements in glucose homeostasis compared
to AL (Velingkaar, 2020). Furthermore, they measured an important marker of glucose

homeostasis, the glucose tolerance test (GTT). They found that CR mice had significantly
improved glucose tolerance (100-200 mg/dL range for CR during the entire GTT)

consistently compared to both the TR (100-300 mg/dL range for the entire GTT) and AL
groups (100-400 mg/dL range for the entire GTT), while no difference was seen between
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TRF and AL (Velingkaar, 2020). The researchers suspected that this difference in the

effect on glucose homeostasis could be due to the difference in fasting durations between
these groups, as the TRF mice were fasted for 12 hours and the CR mice were fasted for

22 hours (Velingkaar, 2020). An interesting question raised by Mezhnina et al. study is

whether the duration of fasting contributes to glucose homeostasis, and if there is an
optimal duration of fasting.

1.5 Glucose Tolerance
The GTT is an invaluable tool used to assess how fast glucose can be cleared in the
blood and taken up by tissues. It provides a means of quantification for glucose homeostasis
and regulation. Glucose tolerance is determined largely by insulin: the pancreas’ ability to

secrete it and tissue’s response to it. As previously mentioned, insulin is released by the

pancreas as it senses a rise in glucose in the blood. Insulin acts as a signal to cells/tissues
to uptake the glucose from the blood, lowering blood glucose levels to a homeostatic range.

Glucose tolerance is a measure of how well a subject’s tissues can absorb the glucose, and

this can be affected by several factors. A ‘glucose tolerant’ subject has blood glucose levels
returning to a normal range relatively quickly after an influx of glucose. Broadly, a ‘glucose

intolerant’ subject has a difficult time returning their blood glucose levels to a homeostatic
range, requiring more time than a tolerant subject if they are capable. The actual glucose

tolerance test involves an initial blood glucose measurement, followed by an administration

of glucose, via injection, oral administration, etc. After the administration of glucose, blood
glucose levels are measured at various times to examine how well the subject is able to

clear the glucose from their blood, returning their blood glucose levels to a normal level.
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Human applications of a GTT include those that detect type 2 diabetes, pre-diabetes, and

gestational diabetes that develops during pregnancy.

Type 2 diabetes and pre-diabetes are very closely linked to insulin resistance, which
coincides with glucose tolerance. Insulin resistance is developed when cells stop

responding to the insulin signal to absorb glucose and blood glucose levels rise. The

process begins when a large amount of glucose enters the bloodstream, in response the

pancreas secretes more insulin to stimulate cells to uptake the glucose, and over time the
cells stop responding to the large amount of insulin signaling making them insulin resistant

(CDC, 2021). The pancreas senses all of the circulating glucose in the blood and it keeps
secreting insulin in an attempt to make the cells respond. Insulin resistance is shown when
the cells do not respond to the insulin, and blood sugar levels keep increasing (CDC, 2020).

Remembering that glucose tolerance is dependent on the ability to clear glucose from the
blood, there is a clear and well-known association between insulin resistance and glucose

tolerance.

1.6 Insulin Signaling
Insulin plays a critical role in glucose homeostasis. Insulin resistance is caused by
disruptions in the insulin signaling pathway. The insulin signaling pathway begins in the

pancreas. The islets of Langerhans are a type of pancreatic cell that make up only 1-2% of
the pancreas, aggregated together like small islands (myDr, 2018). The islets of Langerhans
are endocrine alpha cells, which secrete glucagon and endocrine beta cells. These cells

secrete insulin directly into the blood (myDr, 2018). Once insulin enters the bloodstream
and binds to its tyrosine kinase receptor on insulin-response heavy tissues, such as the liver,

adipose, and skeletal muscle, this binding induces phosphorylation on tyrosine residues on
11

insulin receptor substrate (1RS) proteins (Lizcano, 2002). PI3 kinase is recruited to the
plasma membrane and phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2),
converting PIP2 to phosphatidylinositol 4,5-triphosphate (PIP3) then recruiting protein

kinase B (AKT) to the plasma membrane (Hooper, 2008). Pyruvate dehydrogenase kinase
1 (PDK1) then activates AKT and it enters the cytoplasm, where AKT phosphorylates and

inactivates glycogen synthase kinase 3 (GSK3), promoting glucose storage as glycogen
(Hooper, 2008). Insulin also signals AKT and PI3K to induce the translocation of glucose
transporter, GLUT 4, to the plasma membrane to be the vehicle glucose uses to enter

adipose and skeletal muscle cells (Hooper, 2008). The insulin signaling pathway in skeletal

muscle and adipose tissue is demonstrated in Figure 1.2. In hepatocytes, GLUT2 is located
at the plasma membrane; the glucose transporter does not require translocation (Leturque,

2005). The insulin signaling pathway in liver tissue is demonstrated in Figure 1.2. Upon
insulin signaling in the liver, glucose is taken up by hepatocytes, which decreases

gluconeogenesis and increases glycogen synthesis (LiverTox, 2018). Once glucose is
inside the hepatocyte, it’s converted into glucose-6-phosphate by hexokinase, trapping it
inside the cell and allowing glycolysis to begin, making ATP (Diabetes in Control, 2012).

In the liver, insulin signaling leads to the activation of glycogen synthase results in
glycogen storages, as well as the inhibition of gluconeogenesis, the process by which the
liver produces glucose, via inhibition of PEPCK and G6P (Diabetes in Control, 2012). The

effects of insulin in the liver are more clearly shown in Figure 1.2.
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Figure 1.1 Insulin signaling pathway
On the left: Insulin signaling in skeletal muscle and white adipose tissue starts when
insulin binds to its receptor. IRS 1/2 is phosphorylated in tyrosine, activating PI3K and
Akt. Akt stimulates GLUT4 translocation to cell membranes thus allowing glucose to
enter the cell. This figure was adapted from:
https://www.researchgate.net/publication/262388226 Animal Models of Nutritional Induction
of Type 2 Diabetes Mellitus
On the right: Insulin signaling in hepatocytes of liver tissue starts when insulin binds to its
receptor and the insulin signaling cascade results in phosphorylation/inactivation of
glycogen synthase kinase-3beta (GSK-3β) and activation of glycogen synthase (GS).
Glycogenolysis is reduced (GP, glycogen phosphorylase). Activation/phosphorylation of
the Akt/mTOR complex induces de novo lipogenesis. Glucose is taken up by glucose
transporter, GLUT2, phosphorylated to glucose-6-phosphate (G6P) by glucokinase and
hexokinase (GK/HK) and metabolized in the glycolytic pathway to pyruvate or channeled
via glucose-1-phosphate (G1P) into glycogen synthesis. Glucose-6-phosphate
dehydrogenase (G6PDH) allows G6P into the pentose phosphate pathway (PPP).
Gluconeogenesis is decreased. This figure was adapted from:
https://www.researchgate.net/figure/Schematic-representation-of-the-molecular-mechanismresponsible-for-the_fig7_322132976

Insulin resistance is a hallmark sign of insulin signaling pathway disruption. The

molecular mechanisms of insulin resistance include the downregulation of several parts of

the insulin signaling pathway in skeletal muscle, adipose, and liver tissue. One mechanism

of insulin resistance is the downregulation of the glucose transporter, GLUT4, in
13

adipocytes, leading to a cell’s impaired ability to transport glucose from the blood into the

cell (Sainai, 2010). Insulin resistance in skeletal muscle and adipocytes may also be due to

downregulation of insulin receptor binding, phosphorylation of the tyrosine kinase
receptor, and phosphorylation of IRSs, all of which negatively affect all downstream

targets of the insulin signaling pathway (Invest, 2000). More tissue-specific examples

include IRS downregulation in adipocytes of humans with type 2 diabetes, which reduces
PI3K association with IRS and general activity, ultimately downregulating the signaling

cascade that comes after (Invest, 2000). On the opposite end of that example, in skeletal
muscle cells of humans with type 2 diabetes, IRS expression is normal, while PI3K activity
associated with IRSs is reduced, again leading to the downregulation of the signaling

cascade that follows (Invest, 2000). In rare cases, IRS mutations are possible, leading to

insulin resistance due to impaired insulin signaling in adipose and skeletal muscle (Saini,

2010). Factors such as hyperinsulinemia, stress, mTOR, S6 kinase, inflammation,
hyperlipidemia, obesity, hyperglycemia, and obesity may cause unusual serine
phosphorylation of IRS proteins, lowering their ability to attract and interact with PI3K, in

turn reducing all downstream effects of IRS (Saini, 2010). Mitochondrial dysfunction may

also play a role in resistance, as it was found that in healthy elderly adults with acute
skeletal muscle insulin resistance, there is approximately a 40% reduction in the rates of

oxidative phosphorylation activity, connected to increased intramyocellular and

intrahepatic lipid content (Petersen, 2003). Insulin resistance may be caused by several
factors, individually or working in tandem, that directly affect glucose tolerance and overall
glucose homeostasis.
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1.7 Pancreatic Release of Insulin
Glucose tolerance is affected not only by insulin resistance, but it is also affected by

pancreatic release of insulin. Before insulin resistance can even occur, the pancreas must
secrete insulin. Pancreatic release of insulin behavior, whether it be downregulated or
upregulated, directly affects glucose clearance from the blood by cells, which is glucose
tolerance. To start, glucose stimulates the secretion of insulin by producing, then

amplifying various signals in the insulin-secreting cells of the pancreas, beta cells
(Henquin, 2000). Circulating blood glucose is uptaken by GLUT2, a facilitative glucose

transporter in the plasma membrane of beta cells (Roder, 2016). Glucose then undergoes
glycolysis in the beta cell, producing ATP, which gives an elevated ATP:ADP ratio (Roder,

2016). ATP-sensitive K+ channels close in response to the stimulus of the altered ratio,
resulting in less K+ efflux from the cell, which depolarizes the membrane, opening voltage
gated Ca+ channels (Roder, 2016). A rise in intracellular calcium triggers the fusion of

insulin-containing vesicles with the plasma membrane, mediated by proteins in the SNARE
superfamily, resulting in insulin exocytosis and release of insulin in the blood (Roder,

2016). This insulin secretion process is known as glucose-triggered stimulus-secretion and
several modulators have the potential to stimulate, amplify, or inhibit this process.

Prominent modulators of insulin release are G-protein-coupled receptors, glucose

being a notable ligand for an amplification of insulin secretion in addition to its initial
stimulus effect (Roder, 2016). G-protein-coupled receptors are followed by a signaling

cascade that begins with the conversion of ATP (readily available due to glucose

conversion to energy after a meal) into cyclic adenosine monophosphate (cAMP) by
adenylate cyclase (Roder, 2016). cAMP activates protein kinase A (PKA), which
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modulates K+ and calcium channels via phosphorylation, increasing the amount of

calcium-sensitive insulin-containing vesicles that are readily releasable in pancreatic beta
cells (Roder, 2016). In summary, glucose also increases the amount of insulin-containing

vesicles that are readily releasable, amplifying the effect of insulin secretion. Free fatty
acids (FFAs) also modulate insulin release, but in an inhibitory manner, through fatty acid
metabolism. Short chain FFAs inhibit glucose-stimulated insulin secretion because of

reduced glucose oxidation with the associated decreased ATP/ADP ratio (Roder, 2016). A

study determined that short chain FFAs increased conversion of glucose to lactate
(Ximenes, 2007). Short chain FFAs were seen to cause significant reductions in pyruvate

decarboxylation (Ximenes, 2007). The researchers surmise that the decrease in glucose

oxidation leads to a lower ratio of ATP:ADP (Ximenes, 2007). This lowered ratio
downregulates the entire glucose-triggered insulin secretion process, which requires

membrane depolarization caused by an elevated ATP:ADP ratio. The mentioned methods

of insulin release modulation are only scratching the surface, there are several methods not
mentioned, and even more still unknown.

Both insulin resistance and pancreatic insulin release must be examined to

definitively determine the cause of dissimilar glucose tolerances and glucose
homeostasis. Several studies have investigated if the benefits of CR are dependent on the
fasting component of the diet. This study, too, focuses on the unanswered role of fasting

as it relates to the glucose homeostasis benefits of CR by looking at an important measure
of glucose homeostasis and regulation, glucose tolerance tests. We attempt to find out if
fasting is responsible for the benefits of CR.
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CHAPTER II
MATERIALS AND METHODS

2.1 Experimental Animals
All the animal studies were performed with approval from the Institutional Animal
Care and Use Committee (IACUC) of Cleveland State University (Protocol No. 21124-

KON-S). The care and use of mice were carried out in accordance with the guidelines of
the Institutional Animal Care and Use Committee (IACUC) of Cleveland State University.

All animals were wild-type (WT) mice of C57BL/6J inbred strain background, housed

under standard conditions of 12 hr light/dark cycle (LD 12:12) with lights turned on at 7:00
AM and turned off at 7:00 PM. All animals were fed a regular 18% protein chow diet
except breeders which were maintained on a 19% protein diet (Harlan).

Feeding Regimen
The Ad-Libitum (AL) control group had unrestricted access to food across the day.

Caloric restriction (CR) was started at 3 months of age for the CR experimental group of
mice. For the first week of the diet, the animals were kept on 10% restriction, for the second
week - on 20% restriction and on 30% restriction for the rest of their life and subsequent

experimental measurements. The CR groups received their food once per day at ZT14 (two
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hours after the light was turned off) as this is considered the most physiologically optimal

time for food consumption, as mice are nocturnal animals and their activity peaks during
the night. All groups had unrestricted access to water. Zeitgeber (external cue) is the light
- hence the labeling “ZT” for every time point. The light was on at ZT0 (7:00AM) and off

atZT12 (7:00PM).

The experimental design is further described in Figure 2-1.

Figure 2-1. Experimental design
The flowchart represents the course of life of experimental mice up to the day of the
glucose tolerance test. C57BL/6J wildtype mice on CR ages 4-6 months used for the
glucose tolerance tests. From birth up to reaching adulthood (3-month-old) mice were fed
on an ad-libitum diet (food present in the cage in unlimited amounts 24/7). After reaching
3 months of age, mice of each sex were split into groups by feeding regimen. CR was
introduced to the respective group. CR mice received 70% of their daily food intake as a
single meal once per day at ZT14, 2 hours after the light is turned off. Mice on all diets
had unlimited access to water.
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2.2 Blood Glucose Measurement

Blood for the analysis was collected through the tail vein, the nick was done using
a sterile needle. Blood glucose was measured using CVS Advanced Health Blood Glucose

Meter with CVS Health Advanced Glucose Meter Test Strips.

2.3 Intraperitoneal Glucose Tolerance Test (ip-GTT)
Initial blood glucose was measured using the method in chapter 2.2 before the test
began. After initial measurement, we intraperitoneally injected glucose (1.2 g/kg body

weight dose, Fisher, Hampton, NH) into the mouse and began a timer. Blood glucose was

assayed, as detailed in chapter 2.2, in intervals as indicated: 15, 30,60, 90, and 120 minutes
after glucose injection. All parameters of the ip-GTTs were performed as indicated.

Immediately following the test, mice were given food. Mice had access to water at all

times.

2.4 Fasting
At the designated fasting time, mice that were to be fasted were taken from their

cage and moved to a new, clean cage without food. The transfer to a clean cage at the
start of the fast ensured the mice did not have crumbs to eat in their cage following food
removal. All fasted mice had access to water at all times.

2.5 Statistical Analysis
Data are shown as average +/- standard error of the mean. Microsoft Excel and
Matlab software packages were used for statistical analysis. To assay the effects of duration

of fast and various diets - the analysis was performed using one and two-way repeated

ANOVA, t-test, and Area Under the Curve (AUC). If the effect of diet or duration of fasting
was found to be statistically significant, Bonferroni correction was used to calculate the p19

value for pairwise comparison. P<0.05 was considered as a statistically significant

difference.
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CHAPTER III

RESULTS

3.1 Effect of Diet on Blood Glucose Levels Throughout the Day
To begin to assess glucose homeostasis with the isolated variable of fasting from

CR, blood glucose was measured at various time points throughout the day. CR mice, even
having been fed at the start of the study, maintained the same blood glucose level

throughout the 24 hour period. AL mice also showed a maintenance in blood glucose levels
throughout the day. The fasted AL mice began the study with glucose measurements

similar to AL, but finished the 24 hour fast with measurements similar to CR.

Figure 3-1. Effect of diet on blood glucose throughout the day
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Blood glucose profiles throughout the day in mice (n >30 per diet) subjected to the
following feeding regimens: ad libitum control (AL) - blue circles, solid line; 30% calorie

restriction (CR) - red circles and solid lines; spontaneously fasted (SF) - black circles and
solid lines. Data are represented as mean ± SEM. Light is on at ZT0 and off at ZT12. Food

for the CR group was provided at ZT14 and food was taken away from the SF group at
ZT14. The light bar on the bottom right represents 12 hours when the light was on. The
dark bar - 12 hours when the light was off.

3.2 Effect of Fasted CR in Both Sexes on Glucose Tolerance
After confirming the advanced glucose regulation of CR mice from Figure3-1 of

measuring blood glucose levels throughout the day, the next step is further evaluating
glucose regulation in CR with the aspect of fasting. The next approach used was a glucose

tolerance test (GTT) to measure the body’s ability to clear glucose from the blood after an
influx of glucose from, in this case, an intraperitoneal injection. Three groups of CR mice

were tested: a group of males following 10 hours of fasting, a group of females following

10 hours of fasting, and a group of males following 22 hours of fasting- the experimental

setup is shown in Figure 3-2. GTT was also performed in non-fasted AL mice as a control.
The results in Figure 3-2a show no significant difference between any of the CR groups

as demonstrated by the Area Under the Curve graph in Figure 3-2b. Gender and duration
of fast did not affect the glucose tolerance of the CR mice. All fasted CR groups showed

significantly better glucose tolerance than the non-fasted AL control group. Area Under
the Curve being much higher for the non-fasted AL control group in Figure 3-2b indicates
a significant decrease in tolerance compared to all CR groups.

22

Figure 3-2. Glucose tolerance significantly improved upon male and female fasted
CR mice compared to AL
Glucose tolerance test of mice on CR diet: black circles and solid lines - AL male mice
(n=4); purple circles and solid lines - CR male mice following 10 hours of fasting (n=9),
blue circles and solid lines - CR female mice following 10 hours of fasting (n=7); orange
circles and solid lines - CR male mice following 22 hours of fasting (n=9). Statistically
significant difference (p<0.05) between indicated groups at a particular time point. Data
are represented as mean ± SEM. AL mice assayed at ZT14. Food for CR group was
removed at ZT16 and assayed at ZT2 for 10 hour fast and ZT14 for 22 hour fast.

3.3 Fasting in Ad-libitum Mice Affects Glucose Tolerance

Fasted CR mice show advanced glucose compared to non-fasted AL mice, so we
wanted to examine how fasting alone would impact glucose tolerance. In Figure 3-1, we

saw that fasted AL mice showed improved glucose regulation compared to AL mice, but
the regulation was not as advanced as mice on CR. To evaluate the effect of fasting alone

on glucose tolerance, we fasted AL mice and performed GTT after completing the fast

for comparison to non-fasted AL mice. Beginning with what we consider to be a short
fast, regular AL mice had food removed from their cages spontaneously and were fasted
23

for 8 hours. The experimental setup is shown in Figure 3-3. As seen in Figure 3-3a, the
8 hours fasted AL mice show increased glucose tolerance compared to the non-fasted AL
control group. The next step was to increase the length of fasting to 14 hours to assess the

effect on tolerance, but there was no change in tolerance between the 14 hours fasted AL

group and the non-fasted AL control group as represented in the similar AUC bars in

Figure 3-3b and Figure 3-3e. Because there was no change in tolerance for 14 hours
fasted mice, we believed that a possible plateau had been reached. To assess this, what

we consider to be a long fast, 22 hours, was spontaneously applied to AL mice. The 22
hours fasted AL mice and the non-fasted AL control mice were assayed at the same time

and a reduction in tolerance in the 22 hours fasted mice compared to the control was

observed, seen in Figure 3-3c. In Figure 3-3f the AUC is increased in the 22 hours fasted

group compared to the non-fasted AL group.
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Figure 3-3. Different durations of fasting affect glucose tolerance in AL mice
A) Black circles and solid lines - AL male mice (n=4); orange circles and solid lines - AL
male mice spontaneously fasted for 8 hours (n=4). Statistically significant difference
(p<0.05) between indicated groups. Data are represented as mean ± SEM. Food for the
fasted group was removed at ZT16 and GTT for both groups was performed at ZT0.
B) non-fasted AL mice and 14 hours fasted AL mice: black circles and solid lines - AL
male mice (n=4); green circles and solid lines - AL male mice spontaneously fasted for 14
hours (n=4). No statistical significant difference (p>0.05) between indicated groups. Data
are represented as mean ± SEM. Food for the fasted group was removed at ZT16 and GTT
for both groups was performed at ZT6.
C) non-fasted AL mice and 22 hours fasted AL mice: black circles and solid lines - AL
male mice (n=4); blue circles and solid lines - AL male mice spontaneously fasted for 22
hours (n=4). Statistically significant difference (p<0.05) between groups. Data are
represented as mean ± SEM. Food for the fasted group was removed at ZT16 and GTT for
both groups was performed at ZT14.
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3.4 A Glucose Tolerance Comparison of Short Fasts to Long Fasts
Observable in Figure 3-4a is the opposite effect that short and long fasts have on

glucose tolerance. This led to isolating a short and long fast to directly compare the two.
In Figure 3-4a and Figure 3-4c are two different experimental setups to assay for
differences in glucose tolerance due to fasting durations. The experimental setups are

shown in Figure 3-4. In Figure 3-4a, fasting for GTT began at the same time and the actual
GTT began at two different times, 8 hours after fasting began and 22 hours after fasting
began. In this graph we can see that the 8 hours fasted group shows increased glucose

tolerance compared to the 22 hours fasted group. This conclusion is also represented in

Figure 3-4b, where the longer fasted group has a higher AUC value than the shorter fasted
group. In Figure 3-4c, the AUC is representative of the 8 hour group having improved
glucose tolerance with a lower AUC value. We did the experiment both ways to account

for any time-of-day variance as another control. The results are consistent with the previous

finding, observing that the 22 hours fasted group has decreased tolerance compared to the
8 hours fasted group. These findings are again represented by the AUC differences in

Figure 3-4d, where the 22 hours fasted group has a higher AUC than the 8 hours fasted
group.
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Figure 3-4. Increase in glucose tolerance in short fasts compared to long

Glucose tolerance test of 8 hours fasted AL mice and 22 hours fasted AL mice: orange
circles and solid lines - AL male mice spontaneously fasted for 8 hours (n=4); blue circles

and solid lines - AL male mice spontaneously fasted for 22 hours (n=4). Statistically

significant difference (p<0.05) between groups. Data are represented as mean ± SEM. A/B)
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Food for both groups was removed at ZT16 and GTT for 8 hours fasted mice performed at

ZT0, 22 hours fasted mice at ZT14. C/D) Food for 8 hours fasted group, food was removed
at ZT18 and at ZT4 for 22 hours fasted mice. Both GTTs were performed at ZT2.

3.5 Glucose Tolerance Test Around the Clock as a Control
There are variations in the experimental design of the GTTs, as seen in Figure 32, Figure 3-3, and Figure 3-4. In some circumstances, groups begin fasting at the same
time and test at different times; in other circumstances, groups begin fasting at different
times and test at the same time. This introduces another variable that could alter results of
GTTs, so we introduced an experiment to control for this variable. GTTs were done to

assess tolerance differences at different points around the clock, two done in the light

phase and two done in the dark phase. Tests were performed on non-fasted AL mice at 4

different times in their 12 hour LD cycle, at two points in the dark phase and two points
in the light phase. The experimental setup is shown in Figure 3-5. Glucose tolerance was
not affected by the test being done at different times, seen in Figure 3-5a. Figure 3-5b

shows the respective AUC values and confirms that there is no statistical difference
between any of the tests, suggesting that time-of-day did not have an effect on tolerance.

Duration of fasting was the most essential variable for differences in glucose tolerance.
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Figure 3-5. Glucose tolerance test around the clock as a control
Glucose tolerance test of non-fasted AL mice around the clock: blue circles and solid
lines - AL male mice assayed at ZT0 (n=4); orange circles and solid lines - AL male

mice assayed at ZT6 (n=4); gray circles and solid lines - AL male mice assayed at ZT14

(n=4); green circles and solid lines - AL male mice assayed at ZT22 (n=6). No statistical
significance (p>0.05) between groups. Data are represented as mean ± SEM.

3.6 Glucose Tolerance in Long Fasts
Seeing a decrease in tolerance upon 22 hours of fasting was of particular interest to
us. We decided to drastically increase the duration of fasting with this experiment,

performing GTTs on mice fasted for 36 hours and 48 hours. The experimental setup is

shown in Figure 3-6. With each increase in fasting duration, a significant decrease in
tolerance was seen compared to non-fasted AL mice, shown in Figure 3-6a. This
difference is confirmed by the correlating AUC chart in Figure 3-6b, the 48 hours fasted

group having the largest AUC, followed by the 36 hour group, then the non-fasted AL

group.

Figure 3-6. Glucose tolerance significantly decreased in 36 and 48 hour fasts
Glucose tolerance of 22 hours fasted AL mice, 36 hours fasted AL mice and 48 hours fasted

AL mice: blue circles and solid lines - AL male mice fasted for 22 hours (n=4); pink circles
and solid lines - AL male mice fasted for 36 hours (n=4); yellow circles and solid lines -

AL mice fasted for 48 hours (n=4). Statistically significant difference (p<0.05) between

groups. Data are represented as mean ± SEM. Food for all groups was removed at ZT16
and GTT was performed at ZT18 for 22 hours, ZT4 for 36 hours, and ZT16 for 48 hours.
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CHAPTER IV

DISCUSSION

4.1 Glucose Tolerance in CR Mice
It has been established that CR mice have an advanced ability to maintain their

glucose homeostasis. We are interested in evaluating the fasting component of CR, rather
than the calorie reduction. GTT was performed following 10 hours of fasting in males
and females on CR; and 22 hours of fasting in another group of males on CR, all

compared to AL mice. Our observation reinforced what was currently known of CR.

Regardless of gender and length of fast, CR mice have significantly improved glucose
tolerance compared to AL mice. Glucose tolerance in both male and female groups were
similar, with no statistical difference. It has been hypothesized that the beneficial

longevity effects of CR are mediated by their increased insulin sensitivity/glucose
tolerance. This notion has been questioned due to recent research discussing lifespan

extension in CR mice while simultaneously observing a development of insulin
resistance. It has been shown that mT0RC2 (mammalian target of rapamycin complex 2)

improves longevity in CR mice, but induces insulin resistance when disrupted (Yu,

2019). By adipose tissue-specific deletion of mT0RC2 component, Rictor, researchers
found that whole body insulin sensitivity decreased, but the same lifespan benefits typical
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of CR mice were still observed (Yu, 2019). This leads us to believe that the benefits of
CR relevant to glucose homeostasis may be independent of the lifespan benefits of CR.

While there is discussion of this, wide acceptance would require extensive supportive

evidence, as there is nearly a century of evidence supporting the relationship between
CR’s advanced glucose homeostasis and its longevity benefits.

The mechanism behind the improved glucose homeostasis and subsequent
improved insulin sensitivity is not well established. It is postulated to be due to increased

activation of certain molecules in the insulin signaling pathway (Li, 2017). Multiple
studies have suggested that CR enhances insulin sensitivity through the insulin signaling
pathway via increased activation of Akt, a downstream effector in the pathway (Li,

2017). In agreement with this suggestion, upregulation of insulin-stimulated PI3K (the
upstream activator of AKT) signaling was shown to improve glucose tolerance (Schenk,

2011). It was also found that PI3K upregulation is necessary for the improvement in
insulin sensitivity, but it is not upregulated by the typical PI3K activator, IRS, as IRS
expression was the same in both CR and AL (Davidson, 2002). The researchers on this

study surmise that this could be due to CR 1) acting on a post-PI3K event in the insulin
signaling pathway; 2) altering the localization of components in the insulin signaling

pathway; 3) working with a separate, unknown pathway acting in tandem with PI3K
(Davidson, 2002). It is widely accepted that whichever component of the insulin

signaling pathway is upregulated in CR, the improved insulin-stimulated glucose
transport can be attributed to a pronounced translocation of the GLUT-4 glucose
transporter to the plasma membrane of muscle and adipose compared to AL mice.
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While fasting is a component of CR, fasted mice and CR mice are considered to

be on two different diets that yield different results. It is conflicting to state that the 10
hour fast and 22 hour fast performed on CR mice has the same effect that occurred with

AL mice. Fasted AL mice in all experiments in this study were placed on a spontaneous
fast from the AL diet, which is different from the fasting occuring in CR mice. As

mentioned, our lab found that CR mice are technically fasted for 22 hours a day, feeding

for only 2 hours (Velingkaar, 2020). The GTT that was termed a 10 hour fast, was
performed 10 hours after the mice were finished feeding, so no spontaneous fast was
implemented. The same design was adopted for the 22 hour fast GTT. These mice were

assayed 22 hours after feeding, right before their next designated feed at ZT14. To be
precise, the CR mice were not placed on a forced, spontaneous fast. The assayed CR mice

were simply tested within the normal routine of their daily cycle. This limitation can be
addressed by extending the fast past their daily fast of 22 hours and performing the GTT

to examine if, in a spontaneously fasted state, their glucose tolerance is still improved as

we observed in this study.

The mechanism by which CR improves glucose metabolism and prevents or

reduces insulin resistance remains largely unknown, but is thought to be attributed to a
network of factors. Considering the two systems that control glucose tolerance:

pancreatic release of insulin and the insulin signaling pathway in tissue; the common
hypothesis is that CR acts on the insulin signaling pathway to effect its improvements in
glucose homeostasis.
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4.2 Changes in Glucose Tolerance in Response to a Short Fast
We observed that glucose tolerance improved in AL mice fasted for 8 hours
compared to non-fasted AL mice. For the purpose of our study, 8 hours is considered a

short fast. Short fasts in hopes of improving metabolic health have been gaining
significant popularity in recent years with the rise of intermittent fasting (IF). IF involves
a voluntary fast, where an individual eats freely within a restricted window of time, and

fasts for the remaining hours in the day. The draw to IF being that it forces the body to
first use fat stores as energy to produce weight loss, instead of glucose from frequent

meals throughout the day. The link between IF and glucose homeostasis is of recent
relevance because of the rising popularity of the diet. Studies have shown that IF is linked
to increased glucose tolerance and insulin sensitivity (Trumpfeller, 2020). Some

physicians even suggest forms of IF to diabetic patients to mitigate symptoms of the
disease (Albosta, 2021). However, as discussed in chapter 1.3, it is challenging to
determine whether the increase in insulin sensitivity is due to the fasting or inevitable

long-term calorie reduction involved in most fasting diets similar to IF.

The effect of calories should play a less significant role in the improved glucose

tolerance observed. Regardless of the differences between the spontaneous short fast and
fasting diets that include reduction of calories, our results are consistent with literature.
Short fasts were observed to improve glucose tolerance, but the mechanism through

which it does may be dissimilar to those that reduce calories, and remains largely
unknown.

Glucose tolerance is ultimately dependent on insulin. Insulin stimulates the uptake

of glucose into tissue, clearing it from blood and returning blood glucose levels back to a
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homeostatic range. Because we observed differences in glucose tolerance in fasted AL
mice and non-fasted AL, we must investigate insulin- its release from the pancreas and

subsequent signaling pathway in tissue. While still unclear, it is widely thought that
improvements in glucose homeostasis from fasting originates from alterations in the
insulin signaling pathway, not alterations in the pancreas. A study evaluating insulin
signaling and glucose metabolism in lean versus obese adults reported an increase in

insulin-stimulated Akt phosphorylation after a 12 hour fast in lean adults compared to
obese adults (Bergman, 2007). Another study showed IRS2 associated PI3K activity
increased in the liver of fasted mice (Kubota, 2008). IRS2 is one of the first proteins

involved in insulin signaling as it activates PI3K. This study’s result would then suggest

that fasting increases IRS2 activation of PI3K, resulting in increased insulin sensitivity
and improved glucose tolerance.

It would be useful to assess at what point in fasting is improved glucose tolerance

induced. We could potentially see a more significant improvement in glucose tolerance
upon a shorter fast of 4-6 hours. It would also be useful to extend the short fast to 10 or

12 hours to assess at what point glucose intolerance begins to develop, as we saw no
change between AL and the mice fasted for 14 hours. It is important to note that basal

metabolic rate, an efficacy measure of metabolism, is nearly seven times higher in mice
than in humans (Agoston, 2017). This difference in metabolic rates makes it difficult to

translate findings from mice to humans. For example, the improvement upon short fasting
observed in this study does not directly imply that an 8 hour fast in humans produces the

same result we observed in mice. This consideration should be carefully reviewed when
discussing any translation of findings from mice to humans. It is in our interest to assay
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various proteins involved in the insulin signaling pathway upon short fasting in AL mice
and compare these results to non-fasted AL mice. Findings may help discover a potential
target in the insulin signaling pathway that can be used as a form of therapy for metabolic

disease.

4.3 Changes in Glucose Tolerance in Response to a Long Fast
When we performed the GTT for the 22 hour fast in AL mice and compared it
with non-fasted AL mice, we observed a decrease in glucose tolerance. This was of
particular interest because we were not anticipating a decrease in tolerance. We saw an

improvement in tolerance upon an 8 hour fast and relatively no change in tolerance upon
a 14 hour fast. The blood glucose measurements during the GTT were significantly

increased compared to non-fasted AL mice and the 8 hour fasted AL mice. Because of

the unusually high blood glucose measurements, we postulated that there must be a point

at which a plateau is reached. The increase of fasting duration from 22 hours to 36 hours
decreased tolerance even more, and blood glucose reached very high levels, peaking at

~ 500 mg/dL at 30 minutes. The data suggested that the longer the fast was forced, the
bigger the decrease in glucose tolerance.

We decided to implement an even longer fast to further confirm the observed
trend. AL mice spontaneously fasted for 48 hours demonstrated a GTT that resembles a

plateau, with extreme glucose intolerance. The peaks at 30 minutes after injection for
both the 36 hour fasted mice and the 48 hour fasted mice are similar, both much higher
than the 22 hour fasted mice. However, the 48 hour fasted mice could not bring their

blood glucose levels back down in the same time that the 36 hour fasted mice could.
There is a clear trend showing that spontaneous long fasts in AL mice decrease glucose
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tolerance compared to non-fasted AL mice. Within this trend, we showed that the longer
the fast, the more intolerant the mice become.

Our results support the current literature that has evaluated glucose homeostasis in
relation to different lengths of fasting in various models. One study evaluated insulin

signaling in lean and obese adults fasted for either 12 hours or 48 hours (Bergman, 2007).

The researchers found a decline in insulin signaling in both lean and obese adults upon a
48 hour fast compared to lean and obese adults upon a 12 hour fast (Bergman, 2007). The
decline in insulin signaling is a development of insulin resistance, a possible explanation

for the development of glucose intolerance. Just as we speculated about what is
responsible for improved glucose tolerance upon short fasting, we must investigate the

same question in long fasts. The question then is whether pancreatic insulin release or
insulin signaling is responsible for the decrease in glucose tolerance?

We cannot definitively state that this is due to insulin resistance, because the

mechanism responsible for tolerance differences may be altered before insulin is even
secreted. It is possible that pancreatic insulin release could be reduced upon long lengths

of fasting, or that the insulin signaling pathway is disrupted causing insulin resistance. In
chapter 1.6 we discussed the inhibitory effects of FFA on insulin secretion and it has

been found that FFA concentration increases nearly eightfold during fasting (Salgin,

2012). There is a general agreement that this increase in FFA downregulates insulin
action by inhibiting pancreatic insulin secretion (Bergman, 2007). There is also evidence

that the increased FFA concentration acts on the insulin signaling pathway by reducing
IRS associated PI3K activity or reducing IRS phosphorylation activation. Both of these
IRS associated reductions would decrease glucose transport via GLUT4 in skeletal
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muscle (Griffin, 1999). A study also found that mTOR signaling was significantly down

in skeletal muscle tissue of adult males following 72 hours of fasting (Vendelbo, 2014).

As a reminder, mTOR signaling is one of the mechanisms by which CR mice enact their
advanced glucose homeostasis. Downregulation of mTOR signaling in long fasts is

consistent with the decrease in glucose tolerance we observed in long fasts.
It is less common to observe glucose tolerance being affected by pancreatic

insulin release behavior, rather than insulin signaling, but it has been observed. For
example, we discussed the inhibitory effect FFAs have on pancreatic insulin secretion. It

was also found that higher pancreatic fat content in humans was associated with higher
BMI, waist circumference, and impaired glucose tolerance compared to those with lower

pancreatic fat content (Heni, 2010). It was determined that pancreatic fat had a negative
impact on insulin secretion and may be a factor in pancreatic beta cell dysfunction

resulting in impaired glucose homeostasis (Heni, 2010). However, another study showed

pancreatic fat content was correlated with higher fasting glucose levels and impaired
glucose tolerance without a direct correlation to disruption in beta cell function (Zijl,

2011). While this study did not find a direct correlation between impaired glucose
tolerance and beta cell dysfunction, the idea that beta cell dysfunction is responsible for

impairment of pancreatic insulin release is widely accepted. Decline in beta cell function
is well known to occur in the time before diagnosis of type 2 diabetes and is central in the

disease's progression (Halban, 2014). Addressing beta cell dysfunction is of high
importance in the development of therapeutics for type 2 diabetes and could potentially

be beneficial for those suffering from similar metabolic disorders.
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Our findings were consistent with current literature in that prolonged fasting does

impair glucose homeostasis. The next step is determining the cause of the intolerance
development. Assaying for insulin after a glucose administration will be useful for

determining if intolerance is due to disruptions in pancreatic insulin release. With the
same mindset moving forward discussed in chapter 4.2, we would like to assay various

proteins involved in the insulin signaling pathway upon long fasts in AL mice and
compare results with non-fasted AL mice. Findings of this, too, may help discover a
potential target in the insulin signaling pathway that can be used as a form of therapy for

metabolic disease.

4.4 Future Directions
In our future studies, we plan on assaying for insulin release in fasted (various

lengths), non-fasted, and CR mice after a glucose injection. This requires collecting blood
before the injection and various time points afterward. The blood collection would be
spun, and serum extracted with an ELISA to follow in order to examine insulin levels.

This would help uncover if the differences in glucose tolerance are due to insulin release

behavior. Another future plan is to assay for insulin signaling molecules to assess if
tolerance differences are due to tissue insensitivity/resistance to insulin. This would be

done with an insulin tolerance test, similar to a GTT, or a tissue collection-based method.
This would entail injecting insulin into mice, then collecting liver and skeletal muscle

tissue. A Western blot would follow collection to detect possible changes in the insulin
signaling pathway.
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CHAPTER V

CONCLUSION

It is widely known that mice on a CR diet experience several benefits, most relevant

to this study being the advanced glucose homeostasis and regulation. This was confirmed

by the steady across-the-day blood glucose measurement and the several GTTs done on
CR mice showing advanced glucose tolerance compared to mice of different diets. CR mice

are able to maintain a low and steady blood glucose level at all times, even after feeding,
and can bring their blood glucose level back down to homeostatic range after a glucose

injection. Being that there are two aspects of the CR diet, fasting between meals and the
30% food reduction, we set out to investigate the role of fasting in the benefits of CR.

Ultimately, we found that fasting does affect glucose tolerance, but this effect is very

different depending on the duration of the fast. It was observed that short fasts increase
glucose tolerance compared to non-fasted AL mice, while long fasts decrease glucose

tolerance. When comparing GTTs of all fasting durations with the CR groups, we saw that
the CR groups still had significantly better glucose tolerance than any of the fasted AL

groups. This leads us to believe that fasting is not the only contributor to the improved
glucose tolerance and regulation of the CR mice.
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Figuring out why fasting is not the main contributor to the advanced glucose

tolerance of CR begins with identifying what determines glucose tolerance in the first

place, which is tissue response to insulin. As further discussed in the previous chapter, the
tissue response to insulin could be affected by several things, including pancreatic insulin

release behavior or insulin resistance/insulin signaling behavior in the tissue itself.
Although fasting does have a role in affecting glucose tolerance in CR mice, another

unknown factor plays a more important role.
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